IE64371B1 - Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis - Google Patents

Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Info

Publication number
IE64371B1
IE64371B1 IE156491A IE156491A IE64371B1 IE 64371 B1 IE64371 B1 IE 64371B1 IE 156491 A IE156491 A IE 156491A IE 156491 A IE156491 A IE 156491A IE 64371 B1 IE64371 B1 IE 64371B1
Authority
IE
Ireland
Prior art keywords
cataract
formula
bis
catalase
alkyl
Prior art date
Application number
IE156491A
Other languages
English (en)
Other versions
IE911564A1 (en
Inventor
Simon Jen Tan Mao
Richard Lee Jackson
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of IE911564A1 publication Critical patent/IE911564A1/en
Publication of IE64371B1 publication Critical patent/IE64371B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Anti-Oxidant Or Stabilizer Compositions (AREA)
IE156491A 1990-05-09 1991-05-08 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis IE64371B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,293 US5061734A (en) 1990-05-09 1990-05-09 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Publications (2)

Publication Number Publication Date
IE911564A1 IE911564A1 (en) 1991-11-20
IE64371B1 true IE64371B1 (en) 1995-07-26

Family

ID=24076166

Family Applications (1)

Application Number Title Priority Date Filing Date
IE156491A IE64371B1 (en) 1990-05-09 1991-05-08 Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis

Country Status (11)

Country Link
US (1) US5061734A (de)
EP (1) EP0456209B1 (de)
JP (1) JP3040005B2 (de)
KR (1) KR0168648B1 (de)
AT (1) ATE108652T1 (de)
AU (1) AU631738B2 (de)
DE (1) DE69102936T2 (de)
DK (1) DK0456209T3 (de)
ES (1) ES2060239T3 (de)
IE (1) IE64371B1 (de)
ZA (1) ZA913362B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411741A (en) * 1993-07-29 1995-05-02 Zaias; Nardo Method and composition for skin depigmentation
US5665770A (en) * 1993-11-05 1997-09-09 Gakko Hojin Kinki Daigaku Method for treatment of cataract with radical scavenger
US5677291A (en) * 1993-12-10 1997-10-14 Hoechst Marion Roussel, Inc. Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
US5686450A (en) * 1995-06-07 1997-11-11 Alcon Laboratories, Inc. Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
US5576278A (en) * 1995-06-07 1996-11-19 Alcon Laboratories, Inc. Stable liquid enzyme compositions and methods of use
AU1837197A (en) * 1996-01-26 1997-08-20 United States of America, represented by the Secretary, Department of Health and Human Services, The National Institutes of Health, The Hydroxylamine compositions for the prevention or retardation of cataracts
US5795876A (en) * 1996-04-30 1998-08-18 Hoechst Marion Rousssel, Inc. Method of inhibiting vascular cell adhesion molecule-1 and treating chronic inflammatory diseases with 2, 6-di-alkyl-4-silyl-phenols
US5608095A (en) * 1996-04-30 1997-03-04 Hoechst Marion Roussel, Inc. Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
US6114572A (en) * 1996-11-20 2000-09-05 Hoechst Marion Roussel, Inc. Substituted phenols and thiophenols useful as antioxidant agents
US6670398B2 (en) * 1997-05-14 2003-12-30 Atherogenics, Inc. Compounds and methods for treating transplant rejection
EA009987B1 (ru) * 1997-05-14 2008-04-28 Атеродженикс, Инк. Производные пробукола для лечения заболеваний, опосредованных vcam-1
US6121463A (en) * 1997-06-24 2000-09-19 Hoechst Marion Roussel, Inc. Alkyl-4-silylheterocyclic phenols and thiophenols useful as antioxidant agents
US6133467A (en) * 1997-06-25 2000-10-17 Hoechst Marion Roussel, Inc. 2,6-di-t-butyl-4-[(dimethyl-4-methoxyphenylsilyl)-methyl-oxy]phenol and 2,6-di-t-butyl-4-[(dimethyl-2-methoxy-phenylsilyl)methyloxy]phenol
WO2002087556A2 (en) * 2001-04-11 2002-11-07 Atherogenics, Inc. Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
US8252840B2 (en) * 2007-03-26 2012-08-28 Salutria Pharmaceuticals Llc Methods of derivatives of probucol for the treatment of type II diabetes
US20080280985A1 (en) * 2007-03-27 2008-11-13 Scott Robert A D Methods and Compositions Using Certain Phenolic Derivatives for the Treatment of Diabetes
KR102591391B1 (ko) * 2021-03-03 2023-10-20 이수호 비산 방지 장치

Also Published As

Publication number Publication date
AU631738B2 (en) 1992-12-03
ZA913362B (en) 1992-03-25
EP0456209B1 (de) 1994-07-20
US5061734A (en) 1991-10-29
DE69102936T2 (de) 1994-12-15
KR0168648B1 (ko) 1999-01-15
EP0456209A2 (de) 1991-11-13
AU7527791A (en) 1991-11-14
EP0456209A3 (en) 1992-06-24
JP3040005B2 (ja) 2000-05-08
IE911564A1 (en) 1991-11-20
ATE108652T1 (de) 1994-08-15
DK0456209T3 (da) 1994-09-05
ES2060239T3 (es) 1994-11-16
DE69102936D1 (de) 1994-08-25
KR910019632A (ko) 1991-12-19
JPH04226912A (ja) 1992-08-17

Similar Documents

Publication Publication Date Title
EP0456209B1 (de) Bis(alkyl-substituierte-4-hydroxyphenylthio)alkan-Analoga als Inhibitoren der Kataraktentstehung
US5112870A (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
Meerson et al. The role of lipid peroxidation in pathogenesis of ischemic damage and the antioxidant protection of the heart
Fryer Evidence for the photoprotective effects of vitamin E
AU697404B2 (en) Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
US5691379A (en) Dihydrolipoic acid as an ophthalmological agent to suppress intolerance reactions in the area between implants and living body tissue
US5075116A (en) Composition and method for treatment of macular degeneration
NL192561C (nl) Oftalmische preparaten die bepaalde fenylazijnzuurverbindingen bevatten.
US5658957A (en) Immunostimulating wound healing compositions and method for preparing and using same
NZ290029A (en) Antifungal-wound healing composition comprising an antifungal agent, a pyruvate and antioxidant and a mixture of fatty acids
US5633285A (en) Cytoprotective wound healing compositions and methods for preparing and using same
WO1996037227A1 (en) Dermatological-wound healing compositions and methods for preparing and using same
JP2001501576A (ja) 抗菌性創傷治癒組成物およびそれらの製造法ならびにそれらの使用
NZ288995A (en) Wound healing composition comprising antikeratolytic agent, pyruvate, antioxidant and fatty acid mixture
US5686450A (en) Use of N,N'-bis(mercaptoacetyl) hydrazine derivatives as anticataract agents
US5080886A (en) Pharmaceutical compositions for the prevention and treatment of oxidant injuries
US6001853A (en) Hydroxylamine compositions for the prevention or retardation of cataracts
EP0270046B1 (de) Pharmazeutisches Präparat zur Behandlung des Katarakts
US5563134A (en) Pharmaceutical compositions comprising clozapine and a radical scavenger
US6204295B1 (en) Antioxidant compounds
Swaiman et al. Sea‐blue histiocyte and posterior column dysfunction: A familial disorder
US5248668A (en) Use of purpurogallin and glycosides thereof in treating ischemia in mammals
Horakova et al. Short cerebral ischemia and subsequent reperfusion and treatment with stobadine
US20060258754A1 (en) Method of treating endothelial dysfunction, oxidative stress and related diseases
KR930011995B1 (ko) 백내장 치료용 조성물

Legal Events

Date Code Title Description
MM4A Patent lapsed